Evaluation of Implant Stability Changes in Sites Prepared with Different Osseodensification Techniques: a Prospective Observational Clinical Study
1 other identifier
observational
12
1 country
1
Brief Summary
The goal of this observational study is to compare, within a cohort of patients requiring rehabilitation in two different sites of the premolar area in the upper maxilla, the primary and secondary stability of implants placed in sites prepared using a magnetic mallet and osseodensification burs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedFirst Submitted
Initial submission to the registry
November 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2024
CompletedFirst Posted
Study publicly available on registry
November 8, 2024
CompletedNovember 8, 2024
November 1, 2024
5 months
November 5, 2024
November 5, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Implant primary stability
Insertion torque
At implant insertion
Implant primary stability
Resonance frequency
At implant insertion
Secondary Outcomes (7)
Implant secondary stability
7 days after implant insertion
Implant secondary stability
14 days after implant insertion
Implant secondary stability
21 days after implant insertion
Implant secondary stability
28 days after implant insertion
Implant secondary stability
60 days after implant insertion
- +2 more secondary outcomes
Other Outcomes (3)
Peri-implant marginal bone level stability
Immediately after surgery
Peri-implant marginal bone level stability
Upon delivery of prosthetic rehabilitation (6 months after surgery)
Peri-implant marginal bone level stability
One year of loading
Study Arms (2)
Single tooth edentulism right
single missed teeth
single tooth edentulism left
single missed tooth
Interventions
Under local anesthesia (mepivacaine HCL 2% with epinephrine1:100.000), a minimally invasive full-thickness flap was elevated to expose the alveolar crest. A pilot osteotome (100-P) was used to easily perforate the cortical plate. Subsequently, osteotomes with gradually increasing diameters were employed until the final diameter of 3.2 mm was reached. The sequence of osteotomes and their respective diameters were as follows: 1. Osteotome 100-P: At a height of 8.5 mm, the diameter was 2.2 mm; 2. Osteotome 160: At a height of 8.5 mm, the diameter was 2.8 mm; 3. Osteotome 200: At a height of 8.5 mm, the diameter was 3.2 mm. Implant (4.0x8.5 mm; Anyridge, Megagen, Gyeongbuk, South Korea) was positioned using a surgical motor. A 3 mm high transepithelial abutment (OCTA, Megagen, Gyeongbuk, South Korea) was connected to it using a torque wrench and it was tightened to 30 Ncm. Single sutures in monofilament synthetic polypropylene 4.0 were performed to close flaps around the abutment.
Under local anesthesia (mepivacaine HCL 2% with epinephrine1:100.000), a minimally invasive full-thickness flap was elevated to expose the alveolar crest. The implant site preparation was realized using osseodensification burs at a rotation speed of 1200 rpm. The osseodensification burs sequence was as follows: 1. Initial pilot hole (rotated clockwise); 2. WT1828 bur (rotated counterclockwise), 3. WT2838 bur (rotated counterclockwise). Implant (4.0x8.5 mm; Anyridge, Megagen, Gyeongbuk, South Korea) was positioned using a surgical motor. A 3 mm high transepithelial abutment (OCTA, Megagen, Gyeongbuk, South Korea) was connected to it using a torque wrench and it was tightened to 30 Ncm. Single sutures in monofilament synthetic polypropylene 4.0 were performed to close flaps around the abutment.
Eligibility Criteria
After investigating general and local anamnesis, which included evaluation of systemic illnesses and potential allergies, a dental visit was conducted to formulate a specific treatment plan. If the patient was deemed eligible for the research protocol, an additional periapical radiograph was obtained for each selected site to assess the adequacy of residual bone height. If the available bone height appeared to be sufficient, a second-level radiographic exam, a Cone Beam Computed Tomography (CBCT), was performed to evaluate whether the bone volume was adequate for supporting implant rehabilitation. For patients requiring tooth extraction, this second assessment was performed after six months of healing after extraction.
You may qualify if:
- Age older than 18 years old;
- Indication for an implant-supported rehabilitation in the upper premolar / first molar areas;
- The area in which the implants will be placed must have had at least 6 months of healing;
- No use of grafts or bone substitutes following tooth extraction;
- Bone volume measuring at least 10 mm in height and 6 mm in width;
- In case of two adjacent implants the distance between the natural teeth must be at least 14 mm, composed by twice the width of each implant (4 mm), the distance between them (at least 3 mm) and twice the distance between each teeth (at least 1,5 mm)
- Bone quality belonging to class D3 or D4, following Misch classification
- Absence or decision to not wear a removable prosthesis during the healing period;
- Patients with good and stable oral hygiene;
- Signed informed consent form.
You may not qualify if:
- Acute myocardial infarction within the previous six months;
- Uncontrolled bleeding disorders;
- Uncontrolled diabetes (HBA1c \> 7.5%);
- Radiotherapy in the head-neck area in the previous 48 months;
- Immunocompromised patients (es. AIDS / chemotherapy);
- Current or previous treatment with antiresorptive drugs via intravenous injection;
- Psychological or psychiatric disease;
- Alcohol and /or drugs abuse;
- Heavy smokers (more than 10 cigarettes / day);
- Plaque index \>20% and/or bleeding on probing \>10%
- Pregnant or breastfeeding patients;
- Patients refusing to participate in follow-up checks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Piezosurgery Academylead
- University of Triestecollaborator
Study Sites (1)
Piezosurgery Academy
Parma, Italy, 43100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2024
First Posted
November 8, 2024
Study Start
February 15, 2024
Primary Completion
July 15, 2024
Study Completion
November 5, 2024
Last Updated
November 8, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share